charles m. perou, phd, discusses genomic signatures and dual her2-targeting in breast cancer
Published 10 years ago • 356 plays • Length 2:39Download video MP4
Download video MP3
Similar videos
-
2:22
charles m. perou, phd, discusses predicting outcomes in breast cancer
-
1:29
dr. charles m. perou on the evolution of precision medicine in breast cancer
-
1:04:19
charles perou - keynote breast cancer genomics and genetics
-
37:59
dr. charles perou | distinguished lectureship in breast cancer research | sabcs 2022
-
1:12
charles perou on biomarker assay use in asco breast cancer guideline
-
24:24
palbociclib and letrozole for my metastatic breast cancer
-
6:38
palbociclib shows improved pfs but not improved os for er her2- mbc patients
-
6:47
how to select treatment for her2 breast cancer patients with brain metastasis?
-
1:37
dr. charles perou on molecular differences in lobular breast cancer
-
6:59
interview with charles m. perou, ph.d.
-
1:40
dr. charles perou on next generation sequencing technology
-
2:15
dr. perou reflects on research leading intrinsic subtypes in breast cancer
-
1:49
dr. murthy on dual her2 blockade in her2 breast cancer
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
6:25
interview with charles perou, phd
-
0:21
bringing cancer research to life: charles m. perou, phd, faacr
-
1:31
dr. loi on immune cells in her2 breast cancer
-
8:12
her2 testing in metastatic breast cancer
-
4:12
dr. charles perou - from molecules to more moments
-
0:51
dr. kris explains how gene signatures are used
-
2:19
dr. yardley on importance of tailoring treatment to breast cancer subtypes
-
3:11
dr. carey on assays and intrinsic subtypes of breast cancer